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Calcium/calmodulin-dependent protein kinase II (CaMKII) is highly concentrated in the brain where its activation by the
Ca2+ sensor CaM, multivalent structure, and complex autoregulatory features make it an ideal translator of Ca2+ signals
created by diﬀerent patterns of neuronal activity. We provide direct evidence that graded levels of kinase activity and
extent of T287 (T286 α isoform) autophosphorylation drive changes in catalytic output and substrate selectivity. The catalytic
domains of CaMKII phosphorylate puriﬁed PSDs much more eﬀectively when tethered together in the holoenzyme versus
individual subunits. Using multisubstrate SPOT arrays, high-aﬃnity substrates are preferentially phosphorylated with limited
subunit activity per holoenzyme, whereas multiple subunits or maximal subunit activation is required for intermediate- and
low-aﬃnity, weak substrates, respectively. Using a monomeric form of CaMKII to control T287 autophosphorylation, we
demonstrate that increased Ca2+/CaM-dependent activity for all substrates tested, with the extent of weak, low-aﬃnity substrate
phosphorylation governed by the extent of T287 autophosphorylation. Our data suggest T287 autophosphorylation regulates
substrate gating, an intrinsic property of the catalytic domain, which is ampliﬁed within the multivalent architecture of the
CaMKII holoenzyme.
1. Introduction
Long-term potentiation (LTP) is a long-lasting enhancement
of excitatory postsynaptic currents that many believe to be a
cellular correlate of learning and memory [1]. While LTP
can be observed in multiple areas of the mammalian brain
(as well as in lower organisms), the Schaﬀer collateral/CA3
synapses onto CA1 pyramidal neurons of the hippocampus
are a classic example whereby brief patterns of high-
frequency activity favor LTP to enhance neuronal connectiv-
ity [2]. The opposing change in synaptic plasticity, long-
term depression (LTD), is produced by low ﬁring frequen-
cies [2]. As might be expected, activity-dependent forms of
plasticity like LTP and LTD both require the second mes-
senger calcium (Ca2+). While LTP has been historically
ascribed to kinase activity and LTD to dephosphorylation
and phosphatase activity [3], a common eﬀector system
capable of decoding Ca2+ spike frequency into diﬀerent
functional outputs would be strategically positioned to reg-
ulate both LTP and LTD. The Ca2+/calmodulin- (CaM-)
dependent protein kinase II (CaMKII) is an ideal regulator
of synaptic plasticity because it has complex autoregula-
tory features that make it ideally suited for regulating
activity-dependent plasticity [4–7].
In mammals, CaMKII family is composed of four closely
related isoforms (α, β, γ, and δ) where it regulates diverse
substrates in cellular processes ranging from metabolism
and cell cycle control to Ca2+ homoeostasis and excitability
[8]. Thus, like other multifunctional serine/threonine protein
kinases (e.g., PKA and PKC), CaMKII phosphorylates many
diﬀerent cellular substrates in diﬀerent subcellular compart-
ments to globally coordinate cellular function. CaM is a
ubiquitous Ca2+ sensor that activates CaMKII by binding to
a target domain that disinhibits the autoregulatory domain
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(ARD) to allow substrate binding to the catalytic surface
(Figures 1(a), 1(b), and 1(c)).
The unique multivalent structure of CaMKII permits
complex forms of autoregulation [9, 10]. The CaMKII holo-
enzyme is comprised of 12–14 subunits [11–13] that permits
coincident CaM binding to support an intraholoenzyme-
intersubunit autophosphorylation [14, 15] (T286 α isoform
and T287 β, γ, and δ isoforms) reaction (for convenience,
we use T287 throughout the paper). While CaMKII is
known to undergo autophosphorylation on multiple sites
[16], many of which have unknown functions, the T287
autophosphorylation site within the ARD leads to enhanced
CaM binding aﬃnity in the presence of Ca2+ [17] and
Ca2+/CaM-independent activity (autonomous) in low
Ca2+ [18, 19]. The unique structure and autoregulation
make CaMKII an ideal sensor to encode Ca2+-spike fre-
quency into T287 autophosphorylation; a process inﬂuenced
by Ca2+-spike duration and amplitude [20], phosphatase
activity [21], alternative spliced linker length, and CaM
availability [22, 23].
While CaMKII is present throughout the body, it is
highly enriched at neuronal connections. In fact, CaMKII is
one of the most abundant proteins in the postsynaptic
density (PSD) [24–26], a cytoskeletal organelle located just
underneath the spine plasma membrane that localizes the
postsynaptic signaling machinery with presynaptic release
sites. While CaMKII appears to have multiple functions in
synaptic plasticity, phosphorylation of GluA1 receptors to
regulate their traﬃcking and signaling appears to be critical
for LTP [7]. CaMKII’s role in LTP and Ca2+ signaling in
the postsynaptic compartment is also linked to its ability to
undergo translocation to NMDA receptors and undergo
autophosphorylation [5, 27, 28], processes that might serve
to restrict the kinase to its targets within the PSD. However,
like the second messenger Ca2+, CaMKII is also implicated
in LTD [29, 30]. And while the role of CaMKII in postsynap-
tic LTD has not been as intensively studied as its role in LTP
[4], CaMKII was recently shown to diﬀerentially phosphory-
late two diﬀerent phosphoacceptor sites on GluA1 in LTP
versus LTD [31]. Because LTP is promoted by strong stimuli
versus weak for LTD, one plausible explanation is that graded
levels of CaMKII activity and/or autophosphorylation pro-
mote diﬀerential substrate phosphorylation to induce the
opposing forms of synaptic plasticity. However, recent stud-
ies have revealed little or no impact of autophosphorylation
on the catalytic output of CaMKII [32, 33]. Using puriﬁed
PSDs and immobilized peptide arrays to create a well-
deﬁned multisubstrate system, we test the hypothesis that
the catalytic output and substrate selectivity of CaMKII
are regulated by its activation state. Our data support a
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Figure 1: Molecular structure and schematic models for CaMKII autoregulation and activation. (a–c) Structural representations of CaMKII’s
catalytic domain (green), autoregulatory domain (ARD) (blue), and hub domain (gray). (a) Illustration of CaMKII holoenzyme with detailed
view of the catalytic domain. Adapted X-ray crystal structure shows monomeric human CaMKIIδ11–309 (PDB ID: 2VN9; [11]) in the
autoinhibited state with the ARD (blue) and modiﬁed to include ATP in the active site (PDB ID: 1ATP; [71]). (b) hCaMKIIδ11–335 activated
(PDB ID: 2WEL; [11]) by Ca2+ (red spheres) and calmodulin (CaM) (magenta) and exposing T287 (white) for autophosphorylation.
(c) Linear schematic of CaMKII holoenzyme (CaMKIIholo) and monomeric CaMKII (CaMKIIm, or CaMKII1–317). Expanded view shows the
ARD (blue) with subdivisions R1 (T287 containing region) and R2/R3 (CaM-binding region) [72].
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model whereby T287 autophosphorylation regulates substrate
gating, an intrinsic property of the catalytic domain, which
is ampliﬁed within the multivalent architecture of the
CaMKII holoenzyme.
2. Results
CaMKII translocation and phosphorylation of PSD proteins
are believed to play an important role in postsynaptic mod-
iﬁcations supporting LTP [4–7]. We determined whether
PSD phosphorylation by CaMKII induced by saturating
Ca2+/CaM is equivalent or diﬀerent to monomeric CaMKII
catalytic activity. Conceptually, one might expect that a sim-
ilar number of activated T287 autophosphorylated subunits
(T286 in alpha isoform) would produce similar levels of sub-
strate phosphorylation within the PSD regardless of whether
the catalytic subunits are within a holoenzyme or mono-
meric. While all four CaMKII isoforms exhibit a high degree
of sequence identity in their catalytic and regulatory
domains, we selected the human δCaMKII isoform for its
enhanced stability in our kinase assays. While the association
domain hub was deleted from monomeric CaMKII (1-317)
(Figures 1(a), 1(b), and 1(c)), this recombinant kinase, like
the native holoenzyme, retains its Ca2+/CaM dependence
and undergoes T287 autophosphorylation as an intersubunit
reaction mechanism which we accomplished in a prereaction
(see Materials and Methods). Postsynaptic densities were
acquired from adult rats (male and female Sprague-Dawley)
using diﬀerential centrifugation and detergent extraction
to obtain the PSD Triton-insoluble fraction (see Materials
and Methods) [34, 35]. The PSD preparation displayed a
characteristic size and ultrastructure (data not shown)
and SDS-PAGE separation and a Coomassie blue stain-
ing revealed the complex protein proﬁle characteristic
of PSD preparations.
Our intent was to focus on characterizing PSD phosphor-
ylation from exogenously added CaMKII; therefore, several
steps were taken to accomplish this. First, rat brains were
extracted and snap frozen in liquid nitrogen as rapidly as
possible (~90 secs) after animal sacriﬁce to reduce CaMKII
translocation to the PSDs in response to decapitation [36].
Second, to minimize autonomous activity of endogenous
PSD CaMKII, isolated PSDs were dephosphorylated over-
night using a PP1α catalytic fragment. The 6X-His-tagged
phosphatase was removed the next day using immobilized
metal aﬃnity chromatography. Third, the allosteric small
molecule CaMKII inhibitor, KN93, was included in the
PSD phosphorylation reaction to inhibit endogenous
CaMKII from undergoing T287 autophosphorylation with
addition of Ca2+/CaM (as KN93 prevents Ca2+/CaM bind-
ing/activation but does not inhibit activated T287 autopho-
sphorylated CaMKII). Fourth, phosphatase and protease
inhibitor cocktails were used in the PSD phosphorylation
reactions to disrupt dephosphorylation and proteolysis reac-
tions. Finally, exogenous CaMKII was preautophosphory-
lated at T287 with thiol-ATP (ATPγS) to limit potential
dephosphorylation and to minimize subsequent incorpora-
tion of 32P in exogenous CaMKII autophosphorylation sites.
Postsynaptic densities were phosphorylated (plus
[γ-32P-] ATP) with T287 autophosphorylated holoenzyme
(CaMKIIholo
+P) or monomer (CaMKIIm
+P) in the presence
of Ca2+/CaM. Similar levels of catalytic activity were
applied for both forms of the autophosphorylated CaMKII
(see Materials and Methods). To control for endogenous
Ca2+/CaM-dependent or Ca2+/CaM-independent kinase
activity, PSDs were also phosphorylated in the presence of
Ca2+/CaM or EGTA, respectively. As described in detail in
Materials and Methods, PSD phosphorylation was quantiﬁed
by phosphorimaging of the 32P incorporation following SDS-
PAGE separation of the proteins (Figures 2(a) and 2(b)). The
corresponding phosphorylation data (autoradiography of 32P
incorporated bands) (Figures 2(c) and 2(d)) was scaled to the
total PSD protein in a given sample based on the area under
the curve (AUC) as described in Materials and Methods.
Under these conditions, the addition of Ca2+/CaM alone pro-
duced less than a 2-fold increase in the total phosphorylation
compared to other Ca2+/CaM-independent kinases (the
EGTA condition; Figure 2(d)). The inclusion of exogenous
CaMKIIm
+P produced ~2-fold increase in the phosphoryla-
tion compared toCa2+/CaM-activated PSDs alone, suggesting
that PSD substrates were available to exogenously added
kinase (Figure 2(d)). The CaMKIIholo
+P produced a 6.4-fold
increase in phosphorylation compared to Ca2+/CaM-
activated PSDs (Figure 2(d)). More importantly, compared
to theT287 autophosphorylatedmonomer, therewas a 4.4-fold
increase in total phosphorylation when corrected for endoge-
nous Ca2+/CaM-stimulated phosphorylation (Figure 2(d))
even though the holoenzyme might be expected to have
less accessibility to substrates in the PSD compared to
the monomer because of their size diﬀerence (~750 kDa
versus 35 kDa, resp.).
The amount of CaMKII enzymatic activity (both
Ca2+/CaM stimulated and autonomous) added to the PSD
phosphorylation reaction was determined both before and
after the experiment via a soluble kinase assay using the
CaMKII-speciﬁc peptide AC-2 (see Materials and Methods).
While the catalytic activity of the monomeric kinase was
greater than the holoenzyme at the initiation of the PSD
phosphorylation reaction, the level of activity at the end of
the PSD phosphorylation was similar between monomeric
and multimeric CaMKII (Figure 2(e)). While it is unclear
why a loss of monomeric activity is observed at the end of
the PSD reaction, no loss of enzymatic activity is observed
for either CaMKIIholo
+P or CaMKIIm
+P in the absence of
PSD protein (data not shown). Thus, while the enzymatic
activity of monomeric CaMKII is favored or equal (start or
end of the reaction) to that of the holoenzyme CaMKII, sub-
strate phosphorylation is higher for CaMKII when multiple
subunits are activated within the holoenzyme for a
diﬀusion-restricted environment like the PSD.
Speciﬁcity for the switch-like behavior in CaMKII critical
for LTP [3] may arise from this enzyme’s ability to translate
Ca2+-spike frequency produced by brief patterns of high-
frequency stimulation into graded levels of activity and T287
autophosphorylation [20]. Thus, we testedwhether regulating
the extent of activation within the CaMKII holoenzyme regu-
lates substrate selectivity. However, endogenous eﬀectors,
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scaﬀolding, and other regulatory proteins within the PSD
could complicate our analysis; therefore, we created amultiple
substrate SPOT array in order to explore how graded levels of
CaMKII activity inﬂuence substrate utilization (see Materials
and Methods). An obvious advantage of this immobilized
peptide assay is that diverse substrates can be exposed to iden-
tical conditions without high-aﬃnity substrates dominating
mixed soluble substrate reactions [37]. We selected four
well-studiedCaMKII substrates studiedwith varying aﬃnities
as determined by standard solution kinetics—a high-aﬃnity
substrate (GluN2BS1303, Km=4.6± 1.1 μM) and three
lower-aﬃnity, weak substrates (Syntide, Km=43.5± 2.3 μM;
VimentinS83 and GluA1S849, Km> 1mM). All peptide
sequences are denoted in Materials and Methods.
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Figure 2: Maximally active CaMKII holoenzymes enhance the phosphorylation of PSD proteins over monomeric CaMKII. (a–d) Isolated rat
PSDs were phosphorylated in low (EGTA) or high calcium (Ca2+/CaM) to assess endogenous, copuriﬁed kinases. PSDs were also
phosphorylated with the addition of equal molar catalytic subunits of T287 autophosphorylated CaMKII multimer (CaMKIIholo
+P = diamond)
or monomer (CaMKIIm
+P = circle). (a) Coomassie-stained gel illustrating the PSD proﬁle and the puriﬁed proteins used in the reaction.
Square indicates CaM. (b) Phosphorimaging of the SDS-PAGE showing 32P-phosphoprotein bands. (c) Phosphorylation proﬁle scaled to
total Coomassie-stained protein. Molecular weight markers indicated along the scaled axis (pixels) representing the scaled lane of the
SDS-PAGE. (d) Total phosphorylation for each condition assessed using the area under the curve (AUC) as arbitrary intensity units.
(e) Quantitation of Ca2+-dependent (Ca2+/CaM) and Ca2+-independent (EGTA) enzymatic activity (katal/mol) of CaMKII measured
via soluble peptide assays with radioactive (γ32P) ATP. CaMKII, monomer or multimer, was autophosphorylated at T287 prior to the
PSD phosphorylation (and activity measurement) (see Materials and Methods) (n = 3). Error bars denote± s.d.
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To create graded levels of CaMKII activity and T286 auto-
phosphorylation in conditions of saturating Ca2+/CaM, we
took advantage of the basal, inhibitory (Ca2+/CaM-indepen-
dent) autophosphorylation (i.e., capping) described previ-
ously [38]. Speciﬁcally, naïve multimeric CaMKII is exposed
to Mg2+/ATP for varying times in the absence of Ca2+/CaM.
This is a relatively slow intramolecular autophosphoryla-
tion reaction (complete in 15–20mins) within the CaM-
binding domain (T306 in CaMKIIδ) that blocks subsequent
Ca2+/CaM binding/activation [19, 38–40]. The degree of
inactivation is measured by exposing the Mg2+/ATP-
treated CaMKII to saturating Ca2+/CaM and AC-2 in a
soluble kinase assay (see Materials and Methods). We
expressed maximal catalytic activity as a function of the
number of subunits in the holoenzyme (the human CaMKIIδ
holoenzyme is tetradecameric [11]). This allowed for the
determination of the molar catalytic activity associated
with one catalytic subunit. Using this metric, the average
number of activatable subunits per holoenzyme was calcu-
lated for each inactivation timepoint shown in Figure 3(a)
(see Materials and Methods). Thus, by normalizing our
treated or “capped” holoenzymes to naïve untreated CaMKII
(14/14 subunits), we calculated that residual bulk kinase activ-
ity in solution as represented on average by holoenzymes with
1/14 or 5/14 subunits is available for Ca2+/CaM activation.
Using this capping pretreatment strategy to limit the
number of Ca2+/CaM activatable subunits per holoenzyme,
we observed that one active subunit per holoenzyme
(CaMKIIholo
1/14) displays preferential phosphorylation for
the high-aﬃnity substrate GluN2B (Figure 3(b)). In
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Figure 3: Enhanced phosphorylation of intermediate and weak SPOT substrates with increasing number of active subunits per holoenzyme.
(a) Time-dependent inactivation of CaMKII by basal autophosphorylation. Ca2+/CaM-stimulated activity of CaMKIIholo expressed in
molar terms (katal/mol) and measured via standard soluble peptide (AC-2) assays with radioactive (γ32P) ATP. Enzymatic activity was
measured following preinactivation reactions of various times (see Materials and Methods); mean± s.d. (n = 3). By calculating the average
enzymatic activity per subunit in a fully activatable tetradecameric holoenzyme (i.e., 0min of inactivation), the average number of
activated subunits per holoenzyme was determined for each condition. (b, c) Phosphorylation ([32P] phosphate incorporation) of
immobilized CaMKII substrates (GluN2B, Syntide, GluA1, and Vimentin synthesized via SPOTs) by CaMKIIholo exhibiting 1, 5, or 14
activated subunits per holoenzyme. Substrates ranked from the lowest to the highest Km. (b) Raw SPOT phosphorylation (PSL/mm
2)
represented as mean± s.d. (n = 3). (c) SPOT phosphorylation normalized by the number of subunits activated per holoenzyme and
represented as mean± s.d. (n = 3). One-way ANOVA of log-normalized data with Holm-Šídák posttest compared to GluN2B within each
group (#P < 0 05, ###P < 0 001).
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Figure 3(c), the phosphorylation data was normalized to
account for the diﬀerent levels of “starting” kinase activity
produced by the capping reaction in order to better evaluate
substrate selectivity proﬁles. Unlike GluN2B, increasing the
number of activatable subunits per holoenzyme signiﬁcantly
increases relative phosphorylation of Syntide (intermediate
substrate aﬃnity) andGluA1 andVimentin (weak substrates)
(Figure 3(c)). While minimal changes in GluN2B phosphor-
ylation were observed, a 20-fold increase in Syntide phos-
phorylation by submaximally activated CaMKIIholo
5/14 was
measured (Figure 3(c)). Maximally activated CaMKIIholo
14/14
produced the greatest increase (12-fold) in phosphorylation
of the weakest substrates, GluA1 and Vimentin (Figure 3(c)).
These data indicate that intermediate- and low-aﬃnity
substrates require multiple activated subunits within the
holoenzyme for phosphorylation. In contrast, high-aﬃnity
substrates are preferentially phosphorylatedwhen thenumber
of subunits per holoenzyme is limited. The reduced phos-
phorylation of high-aﬃnity substrates seen in Figure 3(c)
may result from substrates like NR2B possessing T-Site
(i.e., targeting mode) characteristics [41], which allow sub-
strates mimicking the ARD of CaMKII to bind in a mode
that is biochemically distinct from the substrate binding
pocket [42]. These stable, high-aﬃnity interactions may
punish substrate utilization via avidity eﬀects as discussed
further below.
We elected to use the SPOTs immobilized peptide
approach as it has the obvious advantage that multiple
deﬁned substrates can be examined simultaneously without
having the high-aﬃnity substrates dominate the diﬀusion-
limited solution assay. However, it is still important for
these interfacial reactions to obey speciﬁc requirements for
any enzyme analysis, including a nonsaturating reaction
(Figure 4). We observed that less than 2% of the available
peptide for each substrate (as compared to a 24-hour reaction
for GluN2B, Syntide, GluA1, and Vimentin) was phosphory-
lated by CaMKIIholo
+P in our standard reactions (Figure 4(a)).
While we did not extend the phosphorylation reactions longer
than 24hrs, this time point is likely at equilibrium as the
extent of phosphorylation follows an expected ranking based
on substrate aﬃnity (GluN2B> Syntide>GluA1/Vimentin).
Furthermore, we observed minimal diﬀerences between
maximally activated (14/14 subunits) holoenzymes at 60nM
versus 5 nM (Figures 3(b) and 4(a)—inset, resp.), indicating
that while the extent of phosphorylation is sensitive to kinase
concentration, changes in the substrate phosphorylation
proﬁle are not. Thus, for our standard SPOT reactions
(4mins), changes in the phosphorylation proﬁle are not due
to diﬀerential substrate availability.
One caveat of using SPOT arrays for enzyme analysis is
that they can be negatively inﬂuenced by avidity eﬀects
created by multivalent contacts [43]. For example, the bind-
ing aﬃnity of a protein with its immobilized peptide target
increased by over 1000-fold when a dimeric protein is com-
pared to a monomeric variant [44]. Consistent with avidity
eﬀects contaminating CaMKII phosphorylation of the high-
aﬃnity substrates in the SPOT assays, we observed that
phosphorylation for the high- (GluN2B) and intermediate-
aﬃnity (Syntide) substrates was suppressed as the number
of activated subunits within the holoenzyme increased from
5/14 to 14/14. This becomes readily apparent when CaMKII
substrate phosphorylation is normalized to the number of
activated subunits in the capping experiments (Figure 3(c)).
This avidity eﬀect was not seen with monomeric CaMKII,
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Figure 4: Substrate availability and reaction linearity for SPOT phosphorylation reactions. (a–c) Substrate phosphorylation proﬁles ([32P]
phosphate incorporation of SPOT peptides). Phosphorylation time course of CaMKIIholo
+P (a) or CaMKIIm
+P (b) with an expanded view
of 4min reaction (inset); mean± s.d. (n = 3). (c) Phosphorylation by CaMKIIm+P comparing a normal 4min SPOT reaction (c-1) to
reactions with only radioactive secondary 4min reactions with (c-2) or without (c-3) additional kinase in the secondary reaction;
mean± s.d. (n = 3).
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as substrate phosphorylation proﬁle for CaMKIIm
+P follows
the expected proﬁle (i.e., higher aﬃnity, greater substrate
phosphorylation (Figure 4(b))). Again, linearity for themono-
mer CaMKII reaction rates was supported by the observation
that in our standard SPOT reactions, less than 2% of the avail-
able peptide for each substrate (as compared to a 24-hour
reaction for GluN2B, Syntide, GluA1, and Vimentin) was
phosphorylated by CaMKIIm
+P (Figure 4(b)). Conclusive
support for a linear kinase-substrate reaction is supported by
a pulse-chase style reaction in which nearly identical levels of
32P incorporation are obtained when a secondary reaction
occurs on the same SPOTmembrane immediately after an ini-
tial nonradioactive reaction (Figure 4(c)—reaction 1versus 2).
A modiﬁcation of this assay whereby CaMKIIm
+P is applied
to the SPOT membrane in the absence of ATP32 reveals
that bound kinase continues to form product over time
when the membrane is washed and ATP32 is added during
the chase without additional kinase (Figure 3(c)). In total,
our standard SPOT reactions are not limited by substrate
availability nor are they outside of a linear reaction range.
However, because the reduced substrate phosphorylation
of higher aﬃnity substrates with maximally activated
CaMKIIholo
+P is likely contaminated by multivalent avidity
eﬀects, we employed the monomeric kinase to directly
evaluate the contribution of T287 autophosphorylation on
substrate selectivity.
CaMKIIm autophosphorylation at T
287 is a well-con-
trolled, second-order reaction under saturating Ca2+/CaM
conditions [15]. Like with CaMKIIholo
+P, the percentage of
autophosphorylated subunits can be detected using the
high-aﬃnity substrate AC-2 (Figure 5(a)) which exhibits a
1 : 1 correlation in the number of T287 autophosphorylated
subunits and maximal autonomous activity ([Ca2+/CaM-
independent]/[Ca2+/CaM-stimulated]) [45]. Therefore, we
generated populations of CaMKIIm containing varying ratios
of CaMKIIm
−P and CaMKIIm
+P using temperature and time
to vary the extent of autophosphorylated subunits (see
Materials andMethods) (Figures 5(a) and 5(b)). Importantly,
for each condition (i.e., extent of autophosphorylated
CaMKII), the number of CaMKIIm
+P subunits generated in
the prereaction does not change during our standard SPOT
assays, as the level of autonomous activity measured in a
solution assay using the AC-2 substrate is the same pre- and
post-SPOTs (Figure 5(c)). We observed a direct relationship
between the extent of substrate phosphorylation and the
percentage of T287 autophosphorylated subunits in the SPOT
assay (Figure 5(d)). However, intermediate- and low-aﬃnity
substrates (Figure 5(d)) displayed the greatest increases
in their phosphorylation in response to T287 autophos-
phorylation. Interestingly, the phosphorylation proﬁle of
the non-T287 autophosphorylated CaMKIIm (Figure 5(b))
was highly similar to the minimally activated CaMKIIholo
(one subunit/holoenzyme condition in Figure 3(b), sug-
gesting that inactivation (via T306 capping) can allow holo-
enzymes with limited activatable subunits to behave as
non-T287-autophosphorylated monomers. Overall, our data
support the hypothesis that the extent of activation and
T287 autophosphorylation within the CaMKII holoenzyme
functions to broaden the substrate speciﬁcity of CaMKII.
3. Discussion
Like other multifunctional protein kinases, CaMKII exhibits
broad substrate speciﬁcity, targeting substrates involved in
carbohydrate, amino acid and lipid metabolism, neurotrans-
mitter synthesis and release, ion channels, receptors, tran-
scription and translation, cytoskeletal organization and
dynamics, cell cycle control, and Ca2+ homoeostasis [8]. In
the nervous system, the role of CaMKII in synaptic plasticity
has been intensively studied from both its role as a structural
protein and as kinase [4–7]. In fact, while a number of diﬀer-
ent proteins and eﬀector pathways have been implicated in
regulating LTP over the years, CaMKII is considered to be
a key mediator of this plasticity [46]. CaMKII is best known
for signaling in the postsynaptic neuron for regulating the
macromolecular signaling complex known as the PSD, a
cytoskeletal organelle important for postsynaptic function.
CaMKII translocation to the PSD is thought to be a critical
feature of its function [47–51], a process that presumably
functions to sequester and localize CaMKII activated with
postsynaptic activity. The NMDA-R complex is a critical tar-
geting molecule for CaMKII localization to the PSD and a
substrate [27]. CaMKII phosphorylation of S1303 on the
GluN2B subunit of the NMDA-R [52] reduces desensitiza-
tion of the channel and hypothesized to serve as a feed-
forward mechanism to sustain Ca2+ entry during learning
and memory [53]. In addition to NMDA-R targeting,
densin-180 and alpha-actinin also serve to recruit CaMKII
to the PSD, possibly to simultaneously interact with CaMKII
via multivalent contacts to nucleate and create a deﬁned sig-
naling complex [54] for the >40 CaMKII substrates identiﬁed
at the PSD [55–57]. Thus, CaMKII translocation to the PSD
appears to involve complex interactions that function to
restrict CaMKII signaling to active postsynaptic sites.
However, once targeted to the PSD, it is unknown how
diﬀerent substrates are selected to create speciﬁc functional
outputs, including opposing forms of synaptic plasticity
LTP and LTD. Thus, the purpose of our study was to
determine how graded activity and T287 autophosphorylation
impact the output of CaMKII, substrate phosphorylation,
and selectivity.
We reasoned that for graded levels of CaMKII activation
to be important for its signaling, then there should be an
intrinsic advantage for multiple subunits to be activated
within the holoenzyme versus a similar catalytic level of indi-
vidual or monomeric CaMKII molecules in phosphorylating
PSD substrates. Our studies revealed that while we began our
phosphorylation reactions with ~2-fold monomeric CaMKII
activity (as measured via a soluble assay) compared to multi-
meric CaMKII, the native form displays a catalytic advantage
at phosphorylating puriﬁed PSDs in vitro. Thus, while the
early work by Cline and colleagues using viral expression of
monomeric constitutively active CaMKII (T286D) [58–60]
clearly shows that monomeric CaMKII modulates axonal
growth, glutamatergic synapse maturation and stabilization
of dendritic arbors, our work demonstrates that the native
holoenzyme has an advantage over the monomer in PSD
phosphorylation in vitro. We reasoned that the diﬀusion-
restricted substrate environment like the PSD with many
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diﬀerent CaMKII substrates (and targeting proteins) takes
advantage of the multivalent structure of CaMKII [54], a
process that could also take advantage of graded activity
within the same CaMKII holoenzyme. Multivalent interac-
tions between CaMKII and its targeting proteins and
substrates [54] may contribute to the catalytic advantage
observed for native CaMKII over monomeric CaMKII.
Future studies are required to explore the interplay between
autophosphorylation-dependent substrate gating and the
contribution of known PSD targeting proteins (e.g., NR2B,
actin, and actinin) in this enhanced PSD phosphorylation
by autophosphorylated CaMKII.
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Figure 5: CaMKII substrate utilization and selectivity are diﬀerentially altered by T287 autophosphorylation. (a) Schematic representation of
various conditions used to preautophosphorylate CaMKIIm prior to Ca
2+/CaM-stimulated substrate phosphorylation reactions on SPOT
arrays (see Materials and Methods). Essentially, time and/or temperature was altered to generate diﬀerent extents of T287
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+P) as graphically illustrated in (b). (c) As a readout of T287
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data with Holm-Šídák posttest compared to 0% autonomy. #P < 0 05; ##P < 0 01; ###P < 0 001.
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We explored this idea directly using multisubstrate SPOT
membranes with peptide substrates synthesized from well-
known CaMKII substrates. The four model substrates we
selected diﬀered in aﬃnity (GluN2BS1303> Syntide>Vimen-
tinS83 and GluA1S849), possessed divergent phosphorylation
motifs, and have been previously characterized in vivo and
in vitro as protein and peptide substrates. Unlike the other
three substrates, the GluN2BS1303 is a classic example of a
T-site-interacting substrate (i.e., mimics CaMKII’s ARD)
which allows for this substrate to form high-aﬃnity stable
interactions to inﬂuence targeting [42] and catalytic activity
[41, 61]. We elected to use the multisubstrate SPOT array
approach because like isolated PSDs, we can explore CaMKII
phosphorylation of diverse substrates simultaneously in a
diﬀusion-restricted environment; however, unlike the PSD,
the SPOT arrays avoid the intrinsic complexity produced
by endogenous CaMKII, scaﬀolding, and regulatory proteins,
factors that can be envisioned to inﬂuence our enzymatic
analysis of substrate speciﬁcity.
To create graded levels of CaMKII activity autophos-
phorylation, we considered the following. First, the
intraholoenzyme-intermolecular T287 autophosphorylation
reaction is rapid (i.e., seconds) under saturating Ca2+/CaM
conditions [15]. Second, while limiting Ca2+/CaM used to
restrict the activation process, it will ultimately produce a
heterogeneous mixture of activation states in CaMKII
(±T287 autophosphorylation, ±T306 autophosphorylation,
and/or ±Ca2+/CaM activation) that will be diﬃcult to inter-
pret. Third, creating mixed holoenzymes of dead or T287A
mutants in our insect expression system has an obvious
limitation in that quantitatively controlling the mutant to
wild-type subunit ratios within individual holoenzymes will
be diﬃcult. Fourth, inhibitory autophosphorylation is used
by CaMKII in vivo to create “capped” or Ca2+/CaM-
insensitive subunits [4]. Thus, we elected to create graded
levels of CaMKII activation by using this intrinsic property
of CaMKII whereby inhibitory (Ca2+/CaM-independent)
basal autophosphorylation inactivates CaMKII subunits
[19, 38–40]. We created holoenzyme populations with vary-
ing ratios of capped subunits (nonresponsive to Ca2+/CaM
and inactive) by incubating naïve multimeric CaMKII with
Mg2+/ATP. This intramolecular subunit reaction [62] occurs
in the absence of Ca2+/CaM as the autophosphorylation
event leading to capping occurs within the CaM-binding
domain (T306 in δ/β/γ CaMKII and T305 in α CaMKII)
[38]. Using this strategy, we created CaMKII holoenzymes
with graded levels of activity in the presence of saturating
Ca2+/CaM to reveal dramatic shifts in the substrate speciﬁc-
ity of the kinase. Higher aﬃnity substrates appear to be
preferentially phosphorylated when limited subunits are
available for activation per holoenzyme (1/14). However,
intermediate and weak substrates become utilized as multiple
subunits are available for activation within the holoenzyme
(5/15 and 14/14). This analysis requires the assumption
that the capping protocol limiting subunit availability to
Ca2+/CaM is stochastic at the microscopic level (i.e., indi-
vidual subunit). The substrate phosphorylation proﬁle for
the CaMKII multimer (1/14) looks very similar to mono-
meric CaMKII in the absence of T287 autophosphorylation,
suggesting that at the macroscopic level (bulk holoenzymes
in solution), the theoretical 1/14 condition functionally
approximates a single non-T287 autophosphorylated state.
While we did have success in creating CaMKII with
graded levels of activity (under saturating Ca2+/CaM), this
protocol does not have suﬃcient control to separate diﬀerent
activation states (± T287 autophosphorylation in the capped
CaMKII holoenzymes). Therefore, we employed monomeric
CaMKII to explore the speciﬁc question of whether T287
autophosphorylation impacts substrate selectivity.
The role of autophosphorylation in regulating substrate
accessibility was examined more recently and found to have
mild [32] or no eﬀect [33] on substrate phosphorylation.
While diﬀerences in our conclusions may be attributable to
diﬀerent species of CaMKII (human versus rat) and isoforms
(α versus δ), we do not favor these possibilities as the catalytic
domain of all four CaMKII isoforms is highly conserved [9].
Historically, early structure-function studies demonstrated a
lag in substrate catalysis that was relieved by CaMKII auto-
phosphorylation [63]. Our substrate reactions used preauto-
phosphorylated CaMKII and suﬃciently dilute monomeric
CaMKII in order to minimize this caveat. Our studies with
monomer and native multimeric CaMKII indicate that
graded levels of activation and/or T287 autophosphorylation
are important determinants of intermediate and weak sub-
strate phosphorylation. While high-aﬃnity substrate phos-
phorylation is also enhanced by T287 autophosphorylation
in CaMKIIm
+P, the eﬀect was not seen in native CaMKII
due to avidity eﬀects. Whether this CaMKIIholo
+P phenome-
non is simply an artifact of peptide density generated in our
SPOT membranes or operates in complex substrate environ-
ments like the PSD requires additional studies. However, our
studies suggest that high-aﬃnity substrates do not have the
same requirement for T287 autophosphorylation as interme-
diate- or low-aﬃnity substrates. In total, our data consistent
with PSD substrates are tuned for phosphorylation by the
multivalent structure of CaMKII and T287 autophosphoryla-
tion speciﬁcally broadens substrate speciﬁcity by enhancing
intermediate and weak substrate utilization.
4. Conclusions
The unique structure and autoregulation make CaMKII an
ideal sensor to encode Ca2+-spike frequency into graded
levels of activity and T287 autophosphorylation within the
holoenzyme. While this process is inﬂuenced by Ca2+-spike
duration and amplitude [20] as well as phosphatase activity
[21], alternative spliced linker length and CaM availability
[22, 23], how the number of activated subunits and/or extent
of T287 autophosphorylation elicits diﬀerent functional out-
puts is unknown. Our studies indicate that the activation
state of CaMKII, and speciﬁcally T287 autophosphorylation,
is critical drivers of substrate selectivity. Furthermore, our
studies suggest a mechanistic explanation for how CaMKII
signaling could regulate even opposing functional outputs
like LTP and LTD via alterations in substrate selectivity.
Future studies are required to determine if graded activ-
ity and autophosphorylation operates within complex
heterogeneous compartments like the PSD. Furthermore,
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while our highly reduced biochemical studies suggest
that the substrate gating eﬀect of T287 autophosphoryla-
tion is an intrinsic property of the catalytic domain
(and independent of the holoenzyme), further studies
are required to illuminate how this mechanism diﬀeren-
tially regulates substrate accessibility.
5. Materials and Methods
5.1. Expression and Puriﬁcation of CaMKII and Calmodulin.
Recombinant human CaMKIIδ (NCBI RefSeq: NP_742113.1)
with an N-terminal 6xHN tag was integrated into a baculo-
viral construct (BacPAK9-6xHN), ampliﬁed in Sf9 insect
cells (expression systems), and expressed in Hi5 (T. ni;
(Expression Systems)) insect cells [64]. Site-directed muta-
genesis was used to generate monomeric hCaMKIIδ1–317
(i.e., CaMKIIm) (by truncation through the addition of
stop codon at aa318). Kinases were puriﬁed under reduc-
ing conditions by aﬃnity chromatography (NiNTA resin)
followed by size exclusion chromatography (Sephacryl S-400
[holoenzyme] or S-300 [CaMKIIm]) using an Äkta Puriﬁer
(Amersham). SDS-PAGE of the puriﬁed proteins revealed
a single band with purities>98%. Recombinant calmodulin
was expressed and puriﬁed in E.coli as described previously
[12, 65] via boiling, ammonium sulfate precipitation, and
phenyl-sepharose aﬃnity chromatography.
5.2. Postsynaptic Density Puriﬁcation. PSDs were acquired
from male/female adult rats (Sprague-Dawley) using previ-
ously deﬁned procedures involving diﬀerential centrifugation
with various sucrose gradients followed by Triton X-100
extraction and collection of the Triton-insoluble fraction
[34, 35]. Several steps were taken to limit and reduce the
Ca2+/CaM-stimulated and autonomous activity of endoge-
nous CaMKII within the PSDs. Rat brains were extracted
and snap frozen in liquid nitrogen within 90 secs after
sacriﬁcing the animal, as CaMKII is known to activate and
translocate to the PSDs within minutes in response to cell
death [36].
5.3. Postsynaptic Density Phosphorylation. The PSDs were
dephosphorylated to prevent autonomous activity of endog-
enous CaMKII (resulting from prior T287 autophosphoryla-
tion), as well as to reduce the phosphorylation state of
endogenous substrates. This was accomplished with 1.5 μM
PP1α (6xHis puriﬁed) overnight at 4°C or at RT for 2 hours
with shaking in the presence of 50mM HEPES pH7.4,
100mM NaCl, 1mM MnCl2, 0.015 Brij 35, 2.5mM DTT,
10 μMKN-93, and 2x calbiochem protease inhibitor cocktail
set V. Phosphorylation reactions were carried out on dephos-
phorylated PSDs in the presence of 2x phosphatase inhibitor
cocktail (Calbiochem) as well as the small molecule CaMKII
inhibitor KN93 which only inhibits the autoinhibited kinase
(naïve). PSD phosphorylation reactions were carried out
on ~50 μg of dephosphorylated PSDs (see above) in the
presence of 20mM HEPES pH7.4, 100mM NaCl, 10mM
MgCl2, 0.5mM CaCl2, 5 μM CaM, 100 μM cold ATP,
120 μCi/ml [γ-32P]-ATP, and 350 nM CaMKII (per sub-
unit). For reactions involving T287 autophosphorylated
CaMKII, a prereaction was performed in the presence of
20mM HEPES pH7.4, 100mM NaCl, 10mM MgCl2,
0.5mM CaCl2, 5 μM CaM, 500 μM ATPγS, and 3.5 μM
kinase for 10min at 30°C (for monomer) or on ice (for
the holoenzyme). PSD phosphorylation reactions (60 μl
total) were incubated at room temperature for 4min
unless otherwise noted. Reactions were terminated with
the addition of 500 μl of 100mM sodium phosphate
pH7.0, 1M NaCl, and 10mM EDTA) followed by centri-
fugation to obtain a PSD pellet. Pellet was three times in
the same termination buﬀer. The PSD pellet was resus-
pended in 2x LDS sample buﬀer and resuspended using
a horn sonicator. SDS-PAGE was performed followed by
Coomassie staining and drying of the gel. Total protein
was assessed by densitometry of the Coomassie signal
while the extent of radioactive phosphate incorporation
was quantiﬁed using a Fujiﬁlm phosphorimager and proﬁles
measured as photostimulated luminescence (PSL/mm2). The
densitometric intensity data was converted to area under the
curve (AUC) todetermine toprotein or total phosphorylation.
5.4. Soluble Peptide Assays. Soluble peptide substrates (gener-
ally 15mers) were obtained (Biopeptide Co. Inc.) and utilized
in standard radioactive activity assays. In typical Ca2+/CaM-
dependent reactions, 50-200μM substrate was used in the
presence of 50mM HEPES pH7.4, 100mM NaCl, 10mM
MgCl2, 0.2mM CaCl2, 1 μM CaM, 100 μM cold ATP,
60 μCi/ml [γ-32P] ATP, and 5–10 nM CaMKII (per subunit).
In Ca2+/CaM-independent reactions, 5mM EGTA (or
BAPTA) was used to chelate free Ca2+. This constitutive
(i.e., autonomous) activity in the absence of Ca2+ was
expressed, a percentage of the Ca2+/CaM-dependent activity.
Reactions were carried out at 30°C for 1minute and quenched
by spotting ontoWhatman Grade P81 ion exchange chroma-
tography paper (Whatman, GE Healthcare, Piscataway, NJ).
The ﬁlter papers were washed with 75mM phosphoric acid
3 times for 5 minutes each and subsequently quantiﬁed in a
scintillation counter (Beckman) via the Cerenkov counting
method [66, 67]. AC-2 (KKALRRQEtVDAL), a CaMKII sub-
strate derived from the CaMKII T287 autophosphorylation
site was used for standard soluble peptide substrate reactions
as described previously [64, 68].
5.5. Holoenzyme Inactivation. CaMKIIholo (600 nM) was
exposed to inhibitory autophosphorylation (T306/7 capping)
for 0, 5, or 15 minutes in the presence of 50mM HEPES
pH7.4, 100mM NaCl, 10mM MgCl2, and 500 μM ATP.
Inactivated states of CaMKII were then diluted to 60nM
for SPOT substrate phosphorylation reactions (described
below). For all states of preinactivation (0, 5, 8, or 15min),
the SPOT phosphorylation was normalized to the number
of active subunits per holoenzyme (assuming each holoen-
zyme is tetradecameric). The number of active subunits per
holoenzyme was assessed by measuring the Ca2+/CaM-
dependent activity of each inactivation condition in standard
soluble peptide substrate phosphorylation assays using AC-2
peptide. These activity assays were performed at the begin-
ning and end (4min) of the SPOT phosphorylation assay,
their values averaged together. The activity from naïve
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CaMKIIholo (i.e., 0min preinactivation) was considered to
maximal (i.e., all 14 subunits activated) and was thus used
to calculate the average enzymatic activity per subunit.
5.6. Preautophosphorylation Reactions. For reactions involv-
ing T287 autophosphorylated CaMKII, a prereaction was
performed in the presence of 20mM HEPES pH7.4,
100mM NaCl, 10mM MgCl2, 0.5mM CaCl2, 5 μM CaM,
500 μM cold ATP, and 500nM kinase for 10 minutes on
ice. To achieve varying numbers/percentages of T287 autop-
hosphorylated subunits (%AutoP), similar prereactions were
used with 50nM kinase incubation times of 0, 5, or 20
minutes on ice, or 10 minutes at 30°C (Figure 5; precondi-
tions 1–4, resp.).
5.7. In Vitro SPOT Phosphorylation Assay. Peptides (gen-
erally 15mers) were synthesized using the SPOT method
[69, 70] onto β-alanine derivatized cellulose membranes via a
MultiPep synthesizer (Intavis AG, Cologne, Germany). The
peptide blots were blocked with 5% BSA in 50mM HEPES
pH7.4, 100mM NaCl, 1mM EDTA, and 0.02% NP-40 for
30 minutes followed by three washes in 100mM Tris–HCl
pH7.4. Membranes were subjected to a kinase phosphoryla-
tion assay in the presence of 50mM HEPES pH7.4, 100mM
NaCl, 10mM MgCl2, 0.2mM CaCl2, 1 μM CaM, 0.2mg/ml
BSA, 1mM DTT, 100 μM cold ATP, 6–12 μCi/ml (γ-32P)
ATP, and 5–10 nM CaMKII (per subunit). The reactions
were incubated at room temperature for 4 minutes unless
otherwise noted, terminated with three washes (100mM
sodium phosphate pH7.0, 1M NaCl, and 10mM EDTA),
and dried. The extent of radioactive phosphate incorpora-
tion was quantiﬁed using a Fujiﬁlm phosphoimager and
expressed as photostimulated luminescence (PSL/mm2) for
a 1.5mm× 1.5mm circle centered on each spot. Three to
four replicate spots were averaged for each peptide for a
given condition with error bars indicating s.d., unless
otherwise noted. GluN2BS1303 =RNKLRRQHsYDTFVD;
Syntide =PLARTLsVAGLPGKK; GluA1S849 =GFCLIPQQ-
sINEAIR; VimentinS83 =PGVRLLQDsVDFSLA.
5.8. Data and Statistical Analysis. One-way analysis of
variance (ANOVA) with subsequent Holm-Šídák posttest
was performed on log transformed to account for mean-
dependent variances, compared to control (#). Statistical
analyses were performed using SigmaPlot 12.5. Statistical
signiﬁcance is denoted by the number of symbols for diﬀerent
P values (e.g., #P < 0 05, ##P < 0 01, and ###P < 0 001).
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